Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response

Clin Mol Hepatol. 2024 Aug 30. doi: 10.3350/cmh.2024.0726. Online ahead of print.

Authors

Hiroaki Kanzaki^{1

2}, Yujin Hoshida²

Affiliations

¹ Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
² Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, U.S.

PMID: 39218442
DOI: 10.3350/cmh.2024.0726

No abstract available

Keywords: immunotherapy; molecular signatures; predictive biomarker; hepatocellular carcinoma.

Publication types

Editorial